« Previous
Next »
Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 5
, Pages 905-910
, May 2008
Histomorphometric Evaluation of the Effects of Zoledronic Acid on Mandibular Distraction Osteogenesis in Rabbits
References
- Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillofac Surg. 2003;32:528
- Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosis. Injury. 2001;32:14
- . Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clin Orthop Relat Res. 1990;250:81
- Transplantation of osteoblast-like cells to the distracted callus in rabbits. J Bone Joint Surg Br. 1999;81:125
- Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int. 1999;64:542
- Recombinant species-specific growth hormone increases hard callus formation in distraction osteogenesis. Bone. 2002;30:117
- . The effect of low-intensity pulsed ultrasound on callus maturation in tibial distraction osteogenesis. Int Orthop. 2005;29:121
- Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis (A study in immature rabbits). J Bone Joint Surg Br. 2001;83:1069
- Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis. J Bone Miner Res. 2003;18:1300
- . Evaluation of the consolidation period during osteodistraction using computed tomography. Am J Orthod Dentofacial Orthop. 1999;116:254
- . Bisphosphonates in Bone Disease: From the Laboratory to the Patients. ed 4. San Diego: Academic Press; 2000;
- Bisphosphonate action (Alendronate localization in rat bone and effects on osteoclast ultrastructure). J Clin Invest. 1991;88:2095
- Antiresorptive dose-response relationships across three generations of bisphosphonates. Drugs Exp Clin Res. 1989;15:389
- . Overview of bisphosphonates. Cancer. 1997;80(suppl 8):1652
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363
- Protein geranylgeranylation is required for osteoclast formation, function, and survival: Inhibition by bisphosphonates and GGTI-298. J Bone Miner Res. 2000;15:1467
- . Bone metastasis: Pathophysiology and management policy. J Clin Oncol. 1991;9:509
- Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone. 2001;28:465
- Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther. 2001;296:235
- . Chemical and biological prerequisites for novel bisphosphonate molecules: Results of comparative preclinical studies. Semin Oncol. 2001;28(suppl 6):4
- Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases. Cancer Res. 2000;60:2949
- . Fractures after femoral lengthening using the Ilizarov method. J Pediatr Orthop. 1995;15:220
- . Fracture after distraction osteogenesis. J Bone Joint Surg Br. 2000;82:659
- Zoledronic acid improves the mechanical properties of normal and healing bone. Clin Biomech. 2002;17:716
- Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: A histological and therapeutic comparison. Pharmacol Toxicol. 2001;89:149
- Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis. J Oral Maxillofac Surg. 2006;64:1232
- Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis. J Bone Miner Res. 2004;19:1698
- Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone. 2002;31:709
- Increase of bone volume by a nanosecond pulsed laser irradiation is caused by a decreased osteoclast number and an activated osteoblasts. Bone. 2007;40:140
- . New foundations in understanding osteonecrosis of the jaws. (editorial) J Oral Maxillofac Surg. 2004;62:125
- Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005;63:1567
- Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol. 2006;24:945
- . Medullary and odontogenic disease in the painful jaw: Clinicopathologic review of 500 consecutive lesions. Cranio. 2002;20:295
- Bisphosphonate-associated osteonecrosis of the jaw: A review of 35 cases and an evaluation of its frequency in multiple myeloma patients. Leuk Lymphoma. 2007;48:56
This study was supported by Scientific Research Project, Selçuk University, Konya, Turkey.
PII: S0278-2391(07)02110-6
doi: 10.1016/j.joms.2007.12.004
© 2008 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 5
, Pages 905-910
, May 2008
